The COVID-19 pandemic has underscored the importance of understanding the various risk factors that can make certain populations more vulnerable to severe illness. Recent studies suggest that ...
New research reveals a potentially effective COVID-19 pill is in the works. Here’s what infectious disease experts want you ...
Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...
Registry-linked outcomes showed 99.9% received ≥2 vaccine doses and 95.2% received 3 doses, enabling assessment of seroconversion, breakthrough infection, and COVID-19 hospitalization. Monoclonal ...
Doctors report rising hip replacements among young Indians post-COVID, linking steroid use and avascular necrosis to severe ...
Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...
RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the Phase 3 MOVe-NOW clinical trial to evaluate ...
Ebola and COVID-19 are viral diseases with different transmission methods and symptoms. Recent Ebola outbreaks in Africa have ...
Testing positive for COVID-19 is not exactly a positive experience. After all, wanting to go viral these days doesn’t tend to mean wanting to be infected by the severe acute respiratory syndrome ...
4/21/25 (LAPost.com) — Most approved COVID-19 treatments cause few serious side effects, according to new research from the Keck School of Medicine of the University of Southern California. The ...